Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Appointed CFO
Acq. announced
Director departure
Quarterly results
Appointed director
CC transcript

ILLUMINA, INC. (ILMN) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/02/2021 GN Myriad Genetics Joins Forces with Intermountain Precision Genomics for a Comprehensive Offering of Germline and Somatic Tumor Testing Services
01/11/2021 GN Myriad Genetics Forms Strategic Partnership with Illumina in Oncology
09/24/2019 GN Adaptive Biotechnologies Enters Partnership with Illumina to Develop Distributable IVD Test Kits for clonoSEQ and immunoSEQ Dx
10/11/2018 GN Analysis: Positioning to Benefit within Tenet Healthcare, GAIN Capital, Illumina, First Cash, Regis, and Cornerstone OnDemand — Research Highlights Growth, Revenue, and Consolidated Results
08/06/2018 GN Detailed Research: Economic Perspectives on Allete, Sterling Construction, Illumina, PROS, Altra Industrial Motion, and Pacific Biosciences of California — What Drives Growth in Today's Competitive Landscape
06/12/2018 GN Update: Lawsuit for Investors in NASDAQ: ILMN shares against Illumina, Inc. announced by Shareholders Foundation
04/10/2018 GN Loxo Oncology and Illumina to Partner on Developing Next-Generation Sequencing-Based Pan-Cancer Companion Diagnostics
02/14/2018 GN New Research Coverage Highlights Illumina, Vectren, Chemours, Fastenal, Norwegian Cruise Line, and Globalstar — Consolidated Revenues, Company Growth, and Expectations for 2018
11/30/2017 GN Market Trends Toward New Normal in Illumina, Vectren, Chemours, Fastenal, Norwegian Cruise Line, and Globalstar — Emerging Consolidated Expectations, Analyst Ratings
10/24/2017 GN Analysis: Positioning to Benefit within Becton, Dickinson and Company, FedEx, Ulta Beauty, Alliance Data Systems, Illumina, and Arista Networks – Research Highlights Growth, Revenue, and Consolidated Results
06/28/2017 GN Adamas Appoints New Chief Financial Officer
03/07/2017 GN OPKO Subsidiary GenPath Women's Health Announces the Availability of ClariTest™
02/28/2017 GN OPKO Health's GeneDx Announces Participation in Illumina's iHope Program on International Rare Disease Day
02/28/2017 GN OPKO Health's GeneDx Announces Participation in Illumina's iHope Program on International Rare Disease Day
02/13/2017 GN DEADLINE TOMORROW: Levi & Korsinsky, LLP Reminds Shareholders of Illumina, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 14, 2017 – ILMN
02/13/2017 GN DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Illumina Inc. (ILMN) & Lead Plaintiff Deadline: February 14, 2017

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy